< RESOURCES HOME

Showing results for: Pharmaceutical Systems
 

Regulation of COVID-19 Medical Products Infographic

COVID-19 has triggered an urgent need for new medical products, including vaccines, medicines, diagnostics, personal protective equipment (PPE), and other medical devices such as those that deliver oxygen. As researchers rush to develop these products and clinicians plan for their delivery and safe use, national regulatory authorities play an essential public health role in ensuring [more…]

Read More...

Grant Management Solutions Success Stories

In the course of almost 10 years of operation, GMS progressively refined its approach to organizing and implementing short-term technical supported, and has consequently identified the ingredients or best practices it considers to be essential to producing high-quality short-term technical support for grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). [more…]

Read More...

A Checklist for Gender Considerations for Pharmaceutical Systems

Gender disparities vary across health systems and affect access to and use of pharmaceutical products and services. This checklist guides pharmaceutical systems program managers and implementers to assess how gender relates to program goals and objectives. The checklist is intended to catalyze discussion on how to apply strategic, intentional, and resourced technical support for gender [more…]

Read More...

Leveraging HIV, TB, and Malaria Control Programming to Address NCDs

By 2030, more people in sub-Saharan Africa will be affected by diseases associated with wealth than those associated with poverty. How can we adapt and design our programs to address this imminent need? In multiple countries, MSH is leveraging infectious disease platforms to address the growing burden of NCDs. This webinar highlights experience integrating services [more…]

Read More...

From Data to Action: Data-Informed Decision Making in Strengthening Pharmaceutical Systems

This webinar, hosted by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program addresses how access to and use of quality data and information management tools enables governments, healthcare providers, and program managers in low- and middle-income countries (LMICs) to make effective and data-informed decisions. This webinar provides an overview of how [more…]

Read More...

Pharmaceutical Management Considerations for UHC

This webinar describes the steps needed to tailor pharmaceutical management efforts to meet Universal Health Coverage (UHC) objectives and discussed key challenges in core pharmaceutical system functional areas and the evidence-informed approaches undertaken by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. For more information about how pharmaceutical management and systems [more…]

Read More...

What Gets Defined, Gets Measured: Definitions and a Framework for Measuring Pharmaceutical Systems Strengthening

This webinar, hosted by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, defines the terms “pharmaceutical system” and “pharmaceutical systems strengthening” and discusses the identification and piloting of indicators for pharmaceutical systems strengthening, measurement tools, and the rationale for undertaking this work. Click the video to view the webinar.

Read More...

Building blocks of progress: Case studies in pharmaceutical systems strengthening

It takes a resilient pharmaceutical system working within and in support of a functioning health system to ensure access to products and services for the people who need them. Pharmaceutical system strengthening requires a coordinated response from policy makers to the dispenser at the local drug shop. It also requires systems strengthening work in governance, [more…]

Read More...

Challenges to Ensuring Adequate and Timely Funding for MNCH Commodities

As countries pursue the maternal, newborn, and child health (MNCH) targets established under Sustainable Development Goal 3, they will need to ensure the continuous availability of essential health commodities to prevent and treat the conditions that cause morbidity and mortality in those groups. A major issue yet to be adequately addressed is financing for MNCH [more…]

Read More...

UHC 2030 Guidance document to assess a healthcare arena under stress

In recent years, a great deal of debate and rhetoric in global health has focused on the importance of health systems strengthening (HSS), especially in fragile situations. The ways policy-makers conceptualize HSS are, however, multiple and confusing. The goal of the guidance is to help professionals involved in the assessment of health systems under stress [more…]

Read More...